Clinical Trials Directory

Trials / Completed

CompletedNCT01988350

Pancreatic Insufficiency Secondary to Tobacco Exposure

Status
Completed
Phase
Study type
Observational
Enrollment
202 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Accepted

Summary

Pancreatic insufficiency is a condition in which there is a decrease in the production and release of enzymes made in the pancreas, which causes nutrient malabsorption. There are many chronic diseases that can lead to pancreatic insufficiency. In the early stages of this disease, a patient may not experience any symptoms, and the prevalence of pancreatic insufficiency may be underestimated. Smoking has long been recognized as a cause of disease in many organs in the body. Cigarette smoke causes inflammation and damages tissue, including the pancreas. Studies have shown that smoking is an independent risk factor for pancreatic cancer and chronic pancreatitis. It has also been shown that the more a person smokes, the worse his disease will be. Additionally, there are studies that show that smokers have nutritional deficiencies. There are observational and retrospective studies that suggest that pancreatic insufficiency may also be caused by smoking. However, this has not been established, and the relationship has not been examined in a controlled manner. This study examines the relationship between smoking and pancreatic insufficiency in patients who do not have other pancreatic diseases.

Conditions

Timeline

Start date
2013-05-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2013-11-20
Last updated
2013-11-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01988350. Inclusion in this directory is not an endorsement.